iifl-logo-icon 1

Sandu Pharmaceuticals Ltd Cash Flow Statement

53
(-0.80%)
Feb 19, 2025|03:40:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sandu Pharma. FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

1.68

0.92

0.75

-0.03

Depreciation

-0.55

-0.55

-0.6

-0.86

Tax paid

-0.58

-0.19

-0.19

-0.49

Working capital

5.71

-2.3

-5.65

-2.17

Other operating items

Operating

6.24

-2.12

-5.69

-3.57

Capital expenditure

0.12

0.21

0.54

10.63

Free cash flow

6.37

-1.9

-5.15

7.05

Equity raised

47.47

42.43

40.76

32.37

Investing

-0.58

-0.3

0.13

0.26

Financing

-1.23

-8.17

-0.05

0.28

Dividends paid

0

0

0

0

Net in cash

52.04

32.06

35.68

39.97

Sandu Pharma. : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.